Introduction {#S1}
============

SlyA is a transcriptional regulator that belongs to the MarR superfamily of regulators ([@B32]). Since its discovery as an inducer of hemolytic activity ([@B18]), several genes have been shown to be regulated by SlyA in *Salmonella enterica* and in *Escherichia coli*, however their regulons are different in these two bacteria. In *Salmonella*, SlyA controls the expression of genes required for virulence ([@B21]; [@B12]). A *slyA* mutant is impaired for growth within macrophages and is hyper susceptible to oxidative stress ([@B12]). In *E. coli*, SlyA activates the expression of the cryptic hemolysin *hlyE* (*clyA*) ([@B34]; [@B19]), of Type1 fimbriae ([@B20]), of *pagP* involved in lipid A palmitoylation in biofilm ([@B5]), and of K5 capsule gene cluster ([@B7]). In addition to these reports on specific genes, a global study has recently expanded the proposed repertoire of the SlyA regulon in *E. coli*, with cryptic genes coding for potential fimbrial-like adhesins that contribute to biofilm formation ([@B8]). Furthermore, this latter study permitted the refinement of a SlyA binding motif in *E. coli*.

SlyA binds DNA as a dimer. It functions mainly as counter-silencer by antagonizing and displacing the H-NS repressor ([@B24]; [@B33]). Interestingly, in *E. coli*, *slyA* expression is positively autoregulated, independently of H-NS ([@B7]). However, the majority of SlyA targets reported so far are known or predicted to be repressed by H-NS ([@B8]). The condition of induction of *slyA* itself or the potential ligand molecule of SlyA have not been elucidated. SlyA has been crystalized with a bound salicylate molecule and it was shown *in vitro* that this binding inhibited SlyA binding to DNA ([@B11]; [@B31]).

It has been reported that ppGpp nucleotide promotes SlyA dimerization and binding to its target promoters in *Salmonella*, and that ppGpp is required for SlyA activity *in vivo* ([@B39]). ppGpp is an important nucleotide acting as a secondary messenger of the stringent response ([@B22]). This global stress response plays a central role in the physiology of bacteria, and its main role is to slow down ribosome biosynthesis and activity while promoting survival programs. This response has been the subject of a strong and renewed interest in the last years when its importance in pathogenicity and resistance to antibiotics has been (re)discovered ([@B9]; [@B15]). There are two main modes of action of ppGpp, whose relative importances depend on bacteria:in *E. coli* and closely related bacteria, ppGpp binds RNAP in conjunction with DksA, influencing globally the transcriptome landscape of the cell ([@B13]). In addition, ppGpp inhibits enzymes of the guanosine synthesis pathway and ribosomal GTPases ([@B2]). The possible allosteric regulation of SlyA by ppGpp triggered high interest at the time, as shown by its highlight in an important review discussing the role of ppGpp in virulence ([@B9]). If validated, this behavior might have provided a good base for the design of direct ppGpp biosensors that are still missing in the field for live detection and/or imaging of ppGpp in bacteria. However, there has been no further mention of this result or follow-up in the literature. It was only mentioned in a discussion that ppGpp was not required for *fimB* activation by SlyA in *E. coli* ([@B20]).

Therefore, we decided to study and characterize clearly this proposed role of ppGpp in controlling SlyA mechanism. The results presented here, based on a combination of genetics, molecular, and biochemical approaches, show that ppGpp is not directly involved in the molecular mechanism of SlyA dimerization and DNA binding. However, for some SlyA regulated genes (like *hlyE* in *E. coli* or *pagCD* in *Salmonella*), complex regulation network involving H-NS and other global regulators might explain indirect ppGpp effects.

Materials and Methods {#S2}
=====================

Plasmid Constructions {#S2.SS1}
---------------------

Plasmid constructions are described succinctly in [Table 1](#T1){ref-type="table"}. The *slyA* ORFs from *E. coli* or *Salmonella enterica* s. Typhimurium 12023 were amplified by PCR on genomic DNA template using the indicated oligonucleotides and cloned in the pBAD24 (pEB227) and pET-6His-Tev vectors (pEB1188).

###### 

Plasmids.

  **Lab code**   **Name**            **Description**                                                                                  **References**
  -------------- ------------------- ------------------------------------------------------------------------------------------------ ----------------
  pEB227         pBAD24              amp^R^, colE1 ori, PBAD promoter                                                                 [@B14]
  pEB1610        pBAD-SlyA_stm       PCR with primers ebm1026/1027 (EcoRI/XhoI) cloned in pBAD24 (EcoRI/SalI)                         This work
  pEB1609        pBAD-SlyA_eco       PCR with primers ebm1026/1189 (EcoRI/XhoI) cloned in pBAD24 (EcoRI/SalI)                         This work
  pEB0898        pUA66               kana^R^, pSC101 ori, GFPmut2                                                                     [@B36]
  pEB0987        pUA139              kana^R^, pSC101 ori, GFPmut2                                                                     [@B36]
  pEB1994        pUA-*paaA*          PCR with primers ebm1830/1831 cloned in pEB898 (XhoI/BamHI)                                      This work
  pEB2005        pUA-*pagC*\_Stm     PCR with primers ebm1847/1848 cloned in pEB898 (XhoI/BamHI)                                      This work
  pEB2006        pUA-*pagD*\_Stm     PCR with primers ebm1847/1848 cloned in pEB987 (BamHI/XhoI)                                      This work
  pEB1937        pUA-*fimB*          PCR with primers ebm1755/1756 cloned in pEB898 (XhoI/BamHI)                                      This work
  pEB1993        pUA-*elfA*          PCR with primers ebm1832/1833 cloned in pEB898 (XhoI/BamHI)                                      This work
                 pUA-*slyA*          Transcriptional fusions available in the plasmid library described in the indicated reference.   [@B36]
                 pUA-*hlyE*                                                                                                           
                 pUA-*pagP*                                                                                                           
                 pUA-*agaS*                                                                                                           
                 pUA-*ybeT*                                                                                                           
                 pUA-*ssuE*                                                                                                           
                 pUA-*yehD*                                                                                                           
                 pUA-*ybeU*                                                                                                           
                 pUA-*ygeG*                                                                                                           
                 pUA-*agaS*                                                                                                           
                 pUA-*ycjM*                                                                                                           
                 pUA-*yadN*                                                                                                           
  pEB1188        pET-6His-Tev                                                                                                         [@B28]
  pEB1885        pET-6His SlyA_stm   PCR with primers ebm1026/1027 cloned in pEB1188 (EcoRI/XhoI)                                     This work
  pEB2004        pET-6His SlyA_eco   PCR with primers ebm1026/1189 cloned in pEB1188 (EcoRI/XhoI)                                     This work
  pEB0267        pKD46               repA101(ts) Pbad-gam-bet-exo Ampi^R^                                                             [@B10]
  pEB0794        pJL148              -SPA-FRT-kana^R^-FRT Ampi^R^                                                                     [@B37]
  pEB0266        pCP20               pSC101(ts), encoding FLP gene, Ampi^R^, Cam^R^                                                   [@B6]
  pEB0697        pALS10              P*tac-relA*, Ampi^R^                                                                             [@B26]
  pEB0698        pALS13              P*tac*-*relA*(1--455), Ampi^R^                                                                   [@B26]
  pEB0699        pALS14              P*tac*-*relA*(1--331), Ampi^R^                                                                   [@B26]

Transcriptional fusions with GFP were constructed in the pUA66 (pEB898) or pUA139 (pEB987) vector backbone ([@B36]). When available, transcriptional fusions were retrieved from the Zaslaver collection ([@B36]), or else the promoter regions were PCR amplified using the oligonucleotides listed in [Table 2](#T2){ref-type="table"} and cloned between XhoI and BamHI restriction sites. The Ecocyc website ([@B17]) was used for sequence retrieval.

###### 

Oligonucleotides.

  **Lab Code**   **5′ --\>3′ sequence**                                               **Gene**
  -------------- -------------------------------------------------------------------- ---------------
  Ebm623         GCCCTTTCGTCTTCACCTCG                                                 FW promoters
  Ebm629         ATCTCCTTCTTAAATCTAGAGGATC                                            RV promoters
  Ebm1830        CCGCTCGAGTCGCTACTCTCCAGATGTTTCAC                                     PpaaA FW
  Ebm1831        ACGGGATCCTCAAAGCGTTCTTCTTGGGTCAC                                     PpaaA RV
  Ebm1847        CATCTCGAGATGATGTTTCATAGCACCTCCTG                                     PpagC FW
  Ebm1848        ACGGGATCCTAGCACGCTTTATTCCCGCTCC                                      PpagC RV
  Ebm1755        CCGCTCGAGTGCGTTCCCCCATATCTCTAGG                                      PfimB FW
  Ebm1756        ACGGGATCCCCATGCTCTTGCATGCTATGTACC                                    PfimB RV
  Ebm1832        CCGCTCGAGATTCCAGCAAGGAGCTGGAGC                                       PelfA FW
  Ebm1833        ACGGGATCCACGCTGGACGTTGCACATACC                                       PelfA RV
  Ebm1026        ACCGAATTCTTGGAATCGCCACTAGGTTCTG                                      slyA FW
  Ebm1189        ACGCTCGAGTCACCCTTTGGCCTGTAACTC                                       slyA_coli RV
  Ebm1027        TTGCTCGAGTCAATCGTGAGAGTGCAATTCC                                      slyA_salmo RV
  Ebm1855        ATCGCAAAACTTGAGCATAATATCATTGAGTTA CAGGCCAAAGGGATTCCAACTACTGCTAGC     slyA-3Flag FW
  Ebm1856        TAAGTTTGCGTGTGGTCAGGTTACTGACCACA CGCCCCCTTCATTCATATGAATATCCTCCTTAG   slyA-3Flag RV

Strain Constructions {#S2.SS2}
--------------------

The construction of the various strains is described succinctly in [Table 3](#T3){ref-type="table"}. Insertion of the 3Flag sequence in fusion with the *slyA* ORF on the chromosome was done by direct recombination of a PCR fragment amplified with oligonucleotides ebm1855/1856 and pJL148 plasmid ([@B37]) as template, following the Datsenko and Wanner procedure ([@B10]). Deletion mutant alleles obtained from the Keio collection ([@B1]) or tagged alleles obtained by recombination were transduced from one genetic background to another by generalized transduction with phage P1. The kanamycin resistance cassette was removed by transformation with the pCP20 plasmid ([@B6]).

###### 

Strains.

  **Lab code**   **Name**           **Description**                                                                                  **References**
  -------------- ------------------ ------------------------------------------------------------------------------------------------ ----------------
  EB072          BL21(DE3)pLys      Coli B λ(DE3) pLysS(cmR)                                                                         [@B25]
  EB240          BW25113Δ*slyA*     Δ*slyA*::kana^R^                                                                                 [@B1]
  EB126          BW25113Δ*relA*     Δ*relA*::kana^R^                                                                                 [@B1]
  EB559          MG1655Δ*dksA*                                                                                                       [@B28]
  EB761          BW25113Δ*cyaA*     Δ*cyaA*::kana^R^                                                                                 [@B1]
  EB128          BW25113Δ*fis*      Δ*fis*::kana^R^                                                                                  [@B1]
  EB047          BW25113Δ*hns*      Δ*hns*::kana^R^                                                                                  [@B1]
  EB944          MG1655             Wild type reference. F- λ- rph-1                                                                 Lab stock
  EB425          MG1655 ppGpp°      Δ*relA*Δ*spoT*::cat                                                                              [@B28]
  EB1073         MGΔ*slyA*          P1 transduction Δ*slyA*::kana^R^ from                                                            This work
                                    EB240 to EB944. Kanamycin resistance removed with pCP20                                          
  EB1076         MGΔ*slyA*Δ*relA*   P1 transduction Δ*relA*::kana^R^ from EB126 to EB1073. Kanamycin resistance removed with pCP20   This work
  EB1077         ppGpp°\_Δ*slyA*    P1 transduction Δ*spoT*::*cat* from EB425 to EB1076                                              This work
  EB1100         Δ*dksA* Δ*slyA*    P1 transduction Δ*slyA*::kana^R^ from EB240 to EB559. Kanamycin resistance removed with pCP20    This work
  EB781          MGΔ*cyaA*          P1 transduction Δ*cyaA*::kana^R^ from EB761 to EB944. Kanamycin resistance removed with pCP20    This work
  EB743          MGΔ*fis*           P1 transduction Δ*fis*::kana^R^ from EB128 to EB944. Kanamycin resistance removed with pCP20     This work
  EB951          MGΔ*hns*           P1 transduction Δ*hns*::kana^R^ from EB047 to EB944. Kanamycin resistance removed with pCP20     This work
  EB1106         *MG_slyA*-3Flag    PCR ebm1855/1856 on pJL148, λRed recombination in EB944 followed by P1 transduction in EB944     This work
  EB468          MG_ppGpp°          P1 transduction slyA-3Flag-kana^R^ from EB1106 to EB425                                          This work
                 SlyA-3Flag                                                                                                          

Measure of Expression Using Transcriptional Fusions With GFP {#S2.SS3}
------------------------------------------------------------

*Escherichia coli* strains were transformed by the plasmids carrying the GFP transcriptional fusions, with or without pBAD plasmids producing SlyA proteins, and the selection plates were incubated at 37°C for 16 h. 600 μl of LB medium supplemented with the required antibiotics, and 0.05% arabinose for pBAD induction, were inoculated (three to six replicates for each assay) and grown for 16 h at 30°C in 96-well polypropylene plates of 2.2-ml wells under aeration and agitation. Fluorescent intensity measurement was performed in a Tecan infinite M200 plate reader. 150 μl of each well was transferred into a black Greiner 96-well plate for reading optical density at 600 nm (OD600) and fluorescence (excitation, 485 nm; emission, 530 nm). The expression levels were calculated by dividing the intensity of fluorescence by the OD600. After mean values were calculated, values from the control vector were subtracted. The results are given in arbitrary units, because the intensity of fluorescence is acquired with an optimal and variable gain; hence, the absolute values cannot be compared between different panels. The error bars on the figures show the standard error of the mean (SEM).

Purification of SlyA Proteins {#S2.SS4}
-----------------------------

BL21(DE3)pLysS strain was transformed with plasmids pET6HisTev-*slyA_stm* (pEB1885) or pET6HisTev-*slyA_ecoli* (pEB2004). The strains were grown in 500 ml LB at 30°C. At OD~600nm~ = 0.9, 1 mM IPTG was added and the cultures incubated during 6 h at 23°C. The proteins were then purified following the procedure described previously ([@B28]).

Electrophoretic Mobility Shift Assay {#S2.SS5}
------------------------------------

DNA fragments containing the *pagC_stm*, *hlyE*, or *slyA* promoters were obtained by PCR using the corresponding transcriptional fusion plasmids as matrices, and the ebm623 and ebm629 primers that hybridize at the limit of the cloning sites. The PCR fragments were then purified using Macherey Nagel PCR purification kit. 20 nM PCR fragments were incubated with purified SlyA and ppGpp (TriLink Biotechnologies) (see legends of [Figure 4](#F4){ref-type="fig"} and [Supplementary Figure S3](#FS3){ref-type="supplementary-material"} for the concentrations), in a 20 μl final reaction buffer containing 25 mM Tris--HCl (pH 7.2), 10 mM MgCl~2~, 1 mM CaCl~2~, 0.5 mM EDTA, 50 mM KCl, and 5% glycerol. The mix was incubated for 30 min at 20°C. The reactions were then analyzed by native PAGE (Acrylamide 10% 29:1). DNA was stained with GelRed (Fluo-Probes).

*In vivo* Crosslinking With Formaldehyde {#S2.SS6}
----------------------------------------

Cells were pelleted and washed once with 10 mM potassium phosphate buffer, pH 6.8, and resuspended in the same volume, with (+F) or without (-F) formaldehyde 1%. Samples were incubated for 15 min at room temperature. The cells were then pelleted and washed again before solubilization in Laemmli loading buffer (volume normalized according to the OD~600~ of the initial cultures). Before loading on SDS-PAGE, the samples were either heated 10 min at 37°C to maintain the cross-links, or heated 20 min at 96°C to destroy them. SDS-PAGE, electrotransfer onto nitrocellulose membranes, and Western blot analyses were performed as previously described ([@B3]). The monoclonal anti-M2 Flag antibody used for 3Flag tag detection was purchased from Sigma.

Results {#S3}
=======

We wanted to study the effect of ppGpp in the activation of gene expression by SlyA in *E. coli*. In addition to the known SlyA targets *hlyE*, *fimB*, and *slyA* itself, it was reported that SlyA might influence the expression of many genes when overexpressed ([@B8]). Based on this study, we tested a set of transcriptional fusions to select the ones that will allow us to follow the activity of SlyA. We used transcriptional fusions with GFP already available in a published *E. coli* promoter library ([@B36]):*pagP*, *slyA*, *hlyE*, *agaS*, *ybeT*, *ssuE*, *yehD*, *ybeU*, *ygeG*, *agaS*, *ycjM*, and *yadN*. We completed this set by constructing transcriptional fusions missing in the library with the promoters of *elfA*, *fimB*, and *paaA* of *E. coli*, and also with promoters of *Salmonella pagC* and *pagD*, which are regulated by the SlyA/H-NS antagonism and reported to be affected by ppGpp ([@B39]). We then measured the expression of all these transcriptional fusions in wild type and Δ*slyA* strains ([Figure 1A](#F1){ref-type="fig"} and [Supplementary Figure S1A](#FS1){ref-type="supplementary-material"}), as well as in the Δ*slyA* strain overproducing or not SlyA from a pBAD inducible plasmid ([Figure 1B](#F1){ref-type="fig"} and [Supplementary Figure S1B](#FS1){ref-type="supplementary-material"}). From this, we selected 4 reporters that responded robustly to SlyA: *slyA* itself, *paaA*, *hlyE*, and *pagC*\_Stm ([Figure 1](#F1){ref-type="fig"} and [Supplementary Figure S1](#FS1){ref-type="supplementary-material"}).

![*slyA*, *paaA*, *hlyE*, and *pagC*\_stm promoters are induced by SlyA. **(A)** Comparison of transcriptional fusion activity in wild type MG1655 and in the *slyA* mutant EB1073 strains grown overnight at 30°C in LB. **(B)** Transcriptional fusion activity when SlyA protein is overproduced. MG1655 strains transformed by the indicated transcriptional fusions and the pBAD24 (pEB227), pBAD-slyA_ecoli (pEB1609), or pBAD_slyA_stm (pEB1610) plasmids were incubated overnight at 30°C in LB supplemented with 0.05% arabinose. The activities correspond to the ratio between GFP fluorescence and OD~600nm~ of 6 replicates, given in arbitrary units (A.U.). The error bars show the SEM.](fmicb-11-01856-g001){#F1}

The *slyA* transcriptional fusion was the only one to show a strong expression level in the wild type strain ([Figure 1A](#F1){ref-type="fig"}). We therefore compared its expression in strains devoid of ppGpp (strains deleted of the *relA* and *spoT* genes). The absence of ppGpp did not modify the expression of *slyA* ([Figure 2A](#F2){ref-type="fig"}). We then compared the expression of the four transcriptional fusions selected above in Δ*slyA* strains overproducing SlyA, in the presence or in the absence of ppGpp ([Figure 2B](#F2){ref-type="fig"}). For the *slyA*, *paaA*, and *pagC*\_Stm fusions, the absence of ppGpp did not prevent the induction by SlyA. These results indicate that *in vivo*, ppGpp is not required for the mechanism of transcription activation by SlyA.

![*In vivo* induction by SlyA does not require ppGpp. **(A)** Comparison of *slyA* transcriptional fusion activity in wild type MG1655, Δ*slyA* (EB1073), ppGpp° (EB425), and Δ*slyA\_*ppGpp° (EB1077) strains grown overnight at 30°C in LB. **(B)** Effect of pBAD-SlyA overproduction in Δ*slyA* or Δ*slyA\_*ppGpp° strains on the expression of *slyA*, *paaA*, *pagC*\_Stm, and *hlyE* transcriptional fusions, in the same conditions as in [Figure 1B](#F1){ref-type="fig"}. The activities correspond to the ratio between GFP fluorescence and OD~600nm~ of six **(A)** or four **(B)** replicates, given in arbitrary units (A.U.). The error bars show the SEM.](fmicb-11-01856-g002){#F2}

However, the induction of the *hlyE* fusion by SlyA was strongly decreased in the absence of ppGpp ([Figure 2B](#F2){ref-type="fig"}). To characterize better the specific effect of ppGpp on *hlyE*, we tested its induction by SlyA in different mutants for global regulatory factors. First, we tested the action of SlyA in the Δ*dksA* mutant. DksA is a cofactor of the RNA polymerase, required for the regulation of RNAP by ppGpp ([@B13]). While ppGpp is still present in this mutant, *dksA* deletion mimics the global effects of a ppGpp° mutant on gene transcription due to the action of ppGpp on RNA polymerase. While SlyA still activated the expression of the *slyA* transcriptional fusion in the Δ*dksA* mutant, as in the ppGpp° mutant ([Supplementary Figure S2](#FS2){ref-type="supplementary-material"}), SlyA induction of *hlyE* was strongly decreased in the Δ*dksA* mutant, similarly to what was observed in the ppGpp° mutant ([Figure 3A](#F3){ref-type="fig"}). This result suggests that the effect of ppGpp on *hlyE* expression is due to its role in controlling expression through RNAP regulation (at *hlyE* promoter or others), and not to a direct control of SlyA activity. For full activation of its expression, *hlyE* would therefore need both SlyA overproduction (or activation by unknown conditions), and the presence of ppGpp.

![*hlyE* activation by SlyA in global regulatory mutants. Induction of the *hlyE* transcriptional fusion by pBAD-slyA_ecoli was tested in the same conditions as in [Figure 1B](#F1){ref-type="fig"}, in the indicated mutant strains: wt (MG1655), Δ*slyA* (EB1073), Δ*slyA\_*ppGpp (EB1077), Δ*slyA*Δ*dksA* (EB1100), Δ*cyaA* (EB781), Δ*fis* (EB743), and Δ*hns* (EB951). The activities correspond to the ratio between GFP fluorescence and OD~600nm~ of 4 **(A,C)** or 3 **(B)** replicates, given in arbitrary units (A.U.). The error bars show the SEM.](fmicb-11-01856-g003){#F3}

In addition to SlyA, *hlyE* expression is controlled by a network of global regulators, such as H-NS ([@B34]; [@B19]), CRP-cAMP and FNR ([@B30]), and it was also reported that it is negatively regulated by Fis ([@B4]). ppGpp is also a member of this complex network controlling bacterial physiology ([@B27]). Therefore the ppGpp/DksA effect observed on the expression of *hlyE* might be indirect through one or several of these global regulators. We tested *hlyE* induction by SlyA in *hns*, *fis*, and *cyaA* mutants. SlyA was still able to induce *hlyE* expression in *fis* and *cyaA* mutants ([Figure 3B](#F3){ref-type="fig"}). As expected, the expression of hlyE was de-repressed in the Δ*hns* mutant, and not further induced by the presence of SlyA ([Figure 3C](#F3){ref-type="fig"}). This confirmed that SlyA activation of *hlyE* expression is due to the displacement of H-NS. This set of experiments suggests that ppGpp role in *hlyE* expression is not due to an indirect effect through CRP-cAMP or Fis regulators, but probably through the regulation of RNAP at the *hlyE* promoter in synergy with DksA.

Our results obtained *in vivo* suggested that ppGpp had no role in SlyA function, contrary to what was reported before ([@B39]). Therefore, it was necessary to also test the effect of ppGpp on SlyA DNA binding *in vitro*. Using gel shift assays, we were able to detect a robust binding of SlyA on the promoter regions tested:*hlyE*, *slyA*, and *pagC_Stm* ([Supplementary Figure S3A](#FS3){ref-type="supplementary-material"}). We then choose for each binding assay, SlyA/DNA ratios that were just sufficient to detect a shift in order to test the effect of adding ppGpp. With addition of 50 μM or 100 μM ppGpp \[the same concentrations used by [@B39]\], the shifts were not affected ([Figure 4](#F4){ref-type="fig"}). Because we used purified SlyA proteins with a 6his tag fused at the N-terminal, we also performed the same experiments after removing the tag by TEV cleavage. Also, ppGpp might have been trapped with SlyA during the purification, therefore we performed the purifications in a ppGpp null strain and obtained the same negative result ([Supplementary Figure S3B](#FS3){ref-type="supplementary-material"}).

![Effect of ppGpp on SlyA binding to DNA. Electrophoretic mobility shift assays were performed using purified SlyA from *E. coli* \[at 50 (+) or 100 (++) nM\] or purified SlyA from *Salmonella* for the *pagC* experiment \[at 200 (+) or 400 (++) nM\]. For each SlyA concentration, 0, 50, or 100 μM ppGpp were added.](fmicb-11-01856-g004){#F4}

The last reported effect of ppGpp on SlyA, was that it enhanced its dimerization, as shown by *in vivo* cross-linking experiments ([@B39]). In order to detect SlyA by Western blot, we constructed wild type and ppGpp° strains producing a SlyA-3Flag tagged protein expressed from its endogenous locus. SlyA-3Flag was readily detected in the two genetic backgrounds, at the expected size of approximately 20 kDa ([Figure 5A](#F5){ref-type="fig"}). To test the dimerization, we used whole cell cross-linking with formaldehyde. This cross-linker produces covalent bonds that can be destroyed by heating at 96°C. In the wild type background, dimerization of SlyA was clearly detected by cross-linking with formaldehyde ([Figure 5A](#F5){ref-type="fig"}). The dimerization was identical in the ppGpp° background ([Figure 5A](#F5){ref-type="fig"}). In reverse, we decided to test if an excess of ppGpp might affect SlyA dimerization, by overproducing the RelA ppGpp synthase. Plasmids pALS10, pALS13, and pALS14 code, respectively, for a full RelA protein, a constitutively active truncated RelA protein, and an inactive RelA protein ([@B26]). We performed the cross-linking experiment in MG1655 strain transformed by these three plasmids and with induction of RelA variants expression. In the samples with induced ppGpp production (pALS10 and pALS13), SlyA dimerization was not affected, or even slightly diminished ([Figure 5B](#F5){ref-type="fig"}). In conclusion, we were not able to see any positive effect of ppGpp on SlyA dimerization.

![Effect of ppGpp on SlyA dimerization *in vivo*. **(A)** MG1655_SlyA-3Flag (EB1106) and ppGpp°\_SlyA-3Flag (EB1110) strains were grown to OD600 = 1.3. **(B)** Strain MG1655_SlyA-3Flag (EB1106) was transformed by plasmids pALS10, pALS13, and pALS14 (pEB0697, pEB0698, and pEB0699, respectively) ([@B26]). These transformed strains were grown to OD600 = 1.5 and then *relA* expression was induced with 1 mM IPTG for 30 min. Then, for both panels, the cells were cross-linked with formaldehyde as described in section "Materials and Methods." +F, with formaldehyde; --F, without formaldehyde; +/H, with formaldehyde and then heated at 96°C. After SDS-PAGE and Western blot, the SlyA-3Flag tag was detected with monoclonal anti-Flag M2.](fmicb-11-01856-g005){#F5}

Discussion {#S4}
==========

In this study, we showed that ppGpp is not required for SlyA function in *E. coli*. The expression of several reporter genes was still induced by SlyA overproduction in the absence of ppGpp *in vivo*, SlyA binding to DNA was not improved by adding ppGpp *in vitro*, and finally SlyA dimerization was not affected by ppGpp absence or increased levels *in vivo*. Even if the initial report of ppGpp effect on SlyA is now more than 10 years old ([@B39]), we think this information is important and of public good for the community of researchers working on ppGpp. Indeed, we are aware of several groups that were interested in developing ppGpp sensors based on this observation, including ourselves. To our knowledge, no confirmation or disproof of ppGpp effect on SlyA was reported since then, apart from a brief mention that ppGpp had no effect on SlyA control of the *fimB* promoter in *E. coli* ([@B20]). Furthermore, SlyA was not spotted in two independent global studies aiming at identifying ppGpp binding proteins ([@B38]; [@B29]). It is therefore still unclear what molecule can regulate SlyA activity. However, recent work provided strong evidence of SlyA control by Salicylate, which fits with SlyA belonging to the MarR family containing proteins known to respond to small aromatic carboxylate compounds ([@B11]; [@B31]).

The obvious difference that could explain the discrepancy between our work and the one reported in [@B39] is that we have studied the activity of SlyA in *E. coli*, while the previous study was done in *Salmonella* ([@B39]), and that we have studied different reporter genes controlled by SlyA. In particular, the expression of *slyA* itself was a very useful reporter of SlyA action, since it is not dependent on H-NS, and permitted to observe that it was not affected in the absence of ppGpp ([Figure 2A](#F2){ref-type="fig"}). Furthermore, we do not contradict the fact that *pagCD* promoters are shut down in a ppGpp° strain in *Salmonella* as shown in [@B39]. We propose that it is in fact very similar to what we observed for the expression of *hlyE* in *E. coli*, for which SlyA overproduction can partially counteract the negative effect of ppGpp absence ([Figure 2B](#F2){ref-type="fig"}), as it was observed for *pagCD* in *Salmonella* ([@B39]). Production of SlyA_eco or SlyA_stm had identical effects when produced in *E. coli* ([Figure 1B](#F1){ref-type="fig"}). Inversely, it was shown that production of SlyA_eco in *Salmonella* is able to counter silence the expression of *pagC*, similarly, to SlyA_stm ([@B31]). Therefore, we think the molecular mechanism of SlyA is identical in the two bacteria. However, it is clear that the regulons and the physiological role of SlyA are very different in the two bacteria. This difference does not come from the SlyA protein itself, but from the variations in intergenic and regulatory regions of the target genes. A striking difference is for example that SlyA represses its own expression in *Salmonella* ([@B23]; [@B31]), whereas it auto-activates its expression in *E. coli* as we showed here ([Figure 1](#F1){ref-type="fig"}) and as it was demonstrated before ([@B7]). The expression level of *slyA* might also play a role, as it has been suggested that *slyA* expression is much lower in *E. coli* than in *Salmonella* ([@B31]). However, in our experiments, the P*slyA* transcriptional fusion was one of the few to display a robust basal expression level, and we were able to detect the SlyA-3Flag tagged protein expression in *E. coli* ([Figure 5](#F5){ref-type="fig"}). Still, only SlyA overproduction using pBAD-SlyA plasmid permitted to detect expression of *paaA*, *hlyE*, and *pagC*\_Stm, suggesting a strong excess of SlyA is necessary to overcome H-NS repression on these genes.

Concerning the effect of ppGpp on SlyA binding to DNA *in vitro*, and the dimerization of SlyA *in vivo*, the discrepancy between our results and the previous ones ([@B39]) is more difficult to understand. Indeed, the SlyA proteins of *E. coli* and *Salmonella* are highly similar (91% identical and 95% similar over 142 amino acids), and we performed *in vitro* binding experiments with SlyA proteins purified from both *E. coli* and *Salmonella*, including a binding experiment on a similar *Salmonella pagCD* intergenic region as the one used previously ([Figure 4](#F4){ref-type="fig"}). As described in the result section, we performed several control experiments to rule out any effect of the tag or the purification procedure of SlyA proteins ([Supplementary Figure S3B](#FS3){ref-type="supplementary-material"}). For the *in vivo* dimerization detected by cross-linking with formaldehyde, we performed the experiment in an *E. coli* strain producing a SlyA-tagged protein expressed from its endogenous locus. Zhao *et al.* performed this experiment in *Salmonella*, with a SlyA-tagged protein expressed from a plasmid. In this case, an indirect effect of ppGpp on *slyA* expression might explain the different results.

The interpretation of the experiments performed in strains mutated for global regulators (such as ppGpp) is complicated by the mode of action of SlyA, which is not a direct and classical activator, but acts mainly as a counter silencer of H-NS. It has been shown that ppGpp physiological effects are intermixed with global regulators such as Fis, CRP, or H-NS, and even DNA supercoiling state ([@B16]; [@B27]). Therefore, it is to be expected that any tinkering of ppGpp concentrations *in vivo* will affect a complex network of global regulations. Particular promoters such as *pagC* in *Salmonella* or *hlyE* in *E. coli* are controlled by an especially high numbers of specific and global factors, not only H-NS and SlyA, but also PhoPQ and EmrR in the case of *pagC* in *Salmonella* ([@B39]; [@B35]) or CRP and FNR for *hlyE* in *E. coli* ([@B30]; [@B4]). Obviously, these complex regulatory networks might be affected by ppGpp levels, together with a possible direct effect of ppGpp on the RNAP depending on the nature of the promoter itself ([@B13]), as it might be the case for *hlyE* in our study or *pagC* in *Salmonella* ([@B39]). More generally, because ppGpp impacts global regulatory networks central to the physiology of bacteria, our study should be taken as a warning of caution in the interpretation of *in vivo* effects triggered by the modification of ppGpp levels.
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*E. coli*

:   *Escherichia coli*

GFP

:   green fluorescent protein

ppGpp

:   guanosine tetraphosphate.
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